Literature DB >> 27398394

Cocaine Antagonists; Studies on Cocaine Self-Administration.

Takato Hiranita1.   

Abstract

Entities:  

Year:  2015        PMID： 27398394      PMCID： PMC4935982          DOI： 10.4172/2329-6488.1000e125

Source DB:  PubMed          Journal:  J Alcohol Drug Depend        ISSN： 2329-6488


× No keyword cloud information.
  19 in total

1.  The stereotypy-inducing effects of N-substituted benztropine analogs alone and in combination with cocaine do not account for their blockade of cocaine self-administration.

Authors:  Libin Li; Takato Hiranita; Shuichiro Hayashi; Amy H Newman; Jonathan L Katz
Journal:  Psychopharmacology (Berl)       Date:  2012-09-14       Impact factor: 4.530

2.  Relationship between in vivo occupancy at the dopamine transporter and behavioral effects of cocaine, GBR 12909 [1-{2-[bis-(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine], and benztropine analogs.

Authors:  Rajeev I Desai; Theresa A Kopajtic; Dawn French; Amy H Newman; Jonathan L Katz
Journal:  J Pharmacol Exp Ther       Date:  2005-07-13       Impact factor: 4.030

3.  Decreases in cocaine self-administration with dual inhibition of the dopamine transporter and σ receptors.

Authors:  Takato Hiranita; Paul L Soto; Stephen J Kohut; Theresa Kopajtic; Jianjing Cao; Amy H Newman; Gianluigi Tanda; Jonathan L Katz
Journal:  J Pharmacol Exp Ther       Date:  2011-08-22       Impact factor: 4.030

4.  N-substituted benztropine analogs: selective dopamine transporter ligands with a fast onset of action and minimal cocaine-like behavioral effects.

Authors:  Su-Min Li; Theresa A Kopajtic; Matthew J O'Callaghan; Gregory E Agoston; Jianjing Cao; Amy Hauck Newman; Jonathan L Katz
Journal:  J Pharmacol Exp Ther       Date:  2010-11-18       Impact factor: 4.030

Review 5.  Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter.

Authors:  Maarten E A Reith; Bruce E Blough; Weimin C Hong; Kymry T Jones; Kyle C Schmitt; Michael H Baumann; John S Partilla; Richard B Rothman; Jonathan L Katz
Journal:  Drug Alcohol Depend       Date:  2014-12-18       Impact factor: 4.492

6.  Sigma receptor agonists: receptor binding and effects on mesolimbic dopamine neurotransmission assessed by microdialysis.

Authors:  Linda Garcés-Ramírez; Jennifer L Green; Takato Hiranita; Theresa A Kopajtic; Maddalena Mereu; Alexandra M Thomas; Christophe Mesangeau; Sanju Narayanan; Christopher R McCurdy; Jonathan L Katz; Gianluigi Tanda
Journal:  Biol Psychiatry       Date:  2010-10-15       Impact factor: 13.382

7.  Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors.

Authors:  Claus J Loland; Rajeev I Desai; Mu-Fa Zou; Jianjing Cao; Peter Grundt; Klaus Gerstbrein; Harald H Sitte; Amy Hauck Newman; Jonathan L Katz; Ulrik Gether
Journal:  Mol Pharmacol       Date:  2007-10-31       Impact factor: 4.436

8.  Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats.

Authors:  Andrew C Barrett; John R Miller; Jennifer M Dohrmann; S Barak Caine
Journal:  Neuropharmacology       Date:  2004       Impact factor: 5.250

9.  Assessment of reinforcing effects of benztropine analogs and their effects on cocaine self-administration in rats: comparisons with monoamine uptake inhibitors.

Authors:  Takato Hiranita; Paul L Soto; Amy H Newman; Jonathan L Katz
Journal:  J Pharmacol Exp Ther       Date:  2009-02-19       Impact factor: 4.030

10.  A selective dopamine reuptake inhibitor improves prefrontal cortex-dependent cognitive function: potential relevance to attention deficit hyperactivity disorder.

Authors:  Brooke E Schmeichel; Frank P Zemlan; Craig W Berridge
Journal:  Neuropharmacology       Date:  2012-07-11       Impact factor: 5.250
View more
  1 in total

1.  DAT Conformation Does Not Predict the Ability of Atypical Dopamine Uptake Inhibitors to Substitute for Cocaine.

Authors:  Takato Hiranita
Journal:  J Alcohol Drug Depend       Date:  2016-08-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.